Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy

被引：0
|
作者：
A Meireles
C Goldsmith
I El-Ghrably
A Erginay
M Habib
B Pessoa
J Coelho
T Patel
R Tadayoni
P Massin
J Atorf
A J Augustin
机构：
[1] Unit of Ophthalmology,Department of Ophthalmology
[2] CHP-Hospital Santo António,undefined
[3] Unit of Ophthalmology,undefined
[4] Universidade do Porto-Instituto Ciências Biomédicas Abel Salazar,undefined
[5] Unit of Ophthalmology,undefined
[6] James Paget University Hospital,undefined
[7] Unit of Ophthalmology,undefined
[8] James Cook University Hospital,undefined
[9] Unit of Ophthalmology,undefined
[10] Lariboisiere University hospital,undefined
[11] Unit of Ophthalmology,undefined
[12] Sunderland Eye Hospital,undefined
[13] Staedtisches Klinikum Karlsruhe,undefined
来源：
Eye | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：684 / 690
页数：6
相关论文
共 50 条
  • [1] Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy
    Meireles, A.
    Goldsmith, C.
    El-Ghrably, I.
    Erginay, A.
    Habib, M.
    Pessoa, B.
    Coelho, J.
    Patel, T.
    Tadayoni, R.
    Massin, P.
    Atorf, J.
    Augustin, A. J.
    EYE, 2017, 31 (05) : 684 - 690
  • [2] Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema
    Soubrane, G.
    Behar-Cohen, F.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2015, 38 (02): : 159 - 167
  • [3] Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema
    Pessoa, Bernardete
    Coelho, Joao
    Correia, Nuno
    Ferreira, Natalia
    Beirao, Melo
    Meireles, Angelina
    OPHTHALMIC RESEARCH, 2018, 59 (02) : 68 - 75
  • [4] Short Term Results of Fluocinolone Acetonide Intravitreal Implant (Iluvien®) for Diabetic Macular Edema in Highly Treated Eyes
    Dhawlikar, Nisha
    Shah, Sumit P.
    Yarian, David L.
    Prenner, Jonathan L.
    Friedman, Eric S.
    Fine, Howard F.
    Wheatley, H. Matthew
    Roth, Daniel B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [5] Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema
    Yahiya Y. Syed
    Drugs, 2017, 77 : 575 - 583
  • [6] Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema
    Syed, Yahiya Y.
    DRUGS, 2017, 77 (05) : 575 - 583
  • [7] Fluocinolone acetonide (Iluvien) extended-release intravitreal implant for diabetic macular edema
    Carle, Michelle V.
    Chu, Thomas G.
    Boyer, David S.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2014, 9 (02) : 81 - 88
  • [8] Efficacy and safety of corticosteroid implant (Fluocinolone Acetonide (FAc) 0.2 lg/day, Iluvien ®) for management of Diabetic Macular Edema (DME): a real-life study
    Vieira, M.
    Pereira, J.
    Santos, M.
    Arruda, H.
    Sousa, J.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 135 - 136
  • [9] Fluocinolone Acetonide Intravitreal Implant (Iluvien®)In Diabetic Macular Oedema
    Mark Sanford
    Drugs, 2013, 73 : 187 - 193
  • [10] Fluocinolone Acetonide Intravitreal Implant (Iluvien®) In Diabetic Macular Oedema
    Sanford, Mark
    DRUGS, 2013, 73 (02) : 187 - 193
12345